Literature DB >> 5696467

Growth hormone secretion in subjects with ovarian dysgenesis and Turner's syndrome.

S R Meadow, B J Boucher, K Mashiter, M N King, L Stimmler.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1968        PMID： 5696467      PMCID： PMC2020018          DOI： 10.1136/adc.43.231.595

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN： 0003-9888            Impact factor:   3.791


× No keyword cloud information.
  6 in total

1.  IMMUNOASSAY OF SERUM GROWTH HORMONE IN ACROMEGALIC PATIENTS.

Authors:  M HARTOG; M A GAAFAR; B MEISSER; R FRASER
Journal:  Br Med J       Date:  1964-11-14

2.  Turner's syndrome and allied conditions. Clinical features and chromosome abnormalities.

Authors:  P E POLANI
Journal:  Br Med Bull       Date:  1961-09       Impact factor: 4.291

3.  Plasma level of growth hormone and chromosome complement in four patients with gonadal dysgenesis (Turner's syndrome).

Authors:  M FRACCARO; C A GEMZELL; J LINDSTEN
Journal:  Acta Endocrinol (Copenh)       Date:  1960-08

4.  The occurrence of abnormal insulin and growth hormone (HGH) responses to sustained hyperglycaemia in a disease with sex chromosome aberrations (Turner's syndrome). Including a histological study of the pancreas in two such patients.

Authors:  J Lindsten; E Cerasi; R Luft; G Hultquist
Journal:  Acta Endocrinol (Copenh)       Date:  1967-09

5.  Critical analysis of blood sugar measurements in diabetes detection and diagnosis.

Authors:  M J Whichelow; A Wigglesworth; B D Cox; W J Butterfield; M E Abrams
Journal:  Diabetes       Date:  1967-04       Impact factor: 9.461

6.  Growth hormone secretion provoked by insulin-induced hypoglycaemia in children of short stature.

Authors:  L Stimmler; G A Brown
Journal:  Arch Dis Child       Date:  1967-06       Impact factor: 3.791
  6 in total
  4 in total

1.  Plasma GH responses to GHRH, arginine, L-dopa, pyridostigmine, sequential administrations of GHRH and combined administration of PD and GHRH in Turner's syndrome.

Authors:  K Hanew; A Tanaka; A Utsumi
Journal:  J Endocrinol Invest       Date:  1998-02       Impact factor: 4.256

2.  Methionyl human growth hormone in Turner's syndrome.

Authors:  C Rongen-Westerlaken; J M Wit; S L Drop; B J Otten; W Oostdijk; H A Waal; M H Gons; A Bot; J L Van den Brande
Journal:  Arch Dis Child       Date:  1988-10       Impact factor: 3.791

3.  Growth hormone treatment in Turner syndrome accelerates growth and skeletal maturation. Dutch Growth Hormone Working Group.

Authors:  C Rongen-Westerlaken; J M Wit; S M De Muinck Keizer-Schrama; B J Otten; W Oostdijk; H A Delemarre-van der Waal; M H Gons; A Bot; J L Van den Brande
Journal:  Eur J Pediatr       Date:  1992-07       Impact factor: 3.183

4.  Growth hormone treatment of Turner syndrome patients with insufficient growth hormone response to pharmacological stimulation tests.

Authors:  G Massa; M Vanderschueren-Lodeweyckx; M Craen; M Vandeweghe; G van Vliet
Journal:  Eur J Pediatr       Date:  1991-05       Impact factor: 3.183
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.